Last reviewed · How we verify
NCT04239898
Microgreen Consumption for Healthy Aging
NA trial testing Red cabbage microgreens in Aging in 26 participants. Completed in 30 November 2019.
22 November 2019
Quick facts
| Lead sponsor | Colorado State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 26 |
| Start date | 16 July 2019 |
| Primary completion | 22 November 2019 |
| Estimated completion | 30 November 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Red cabbage microgreens
- Red beet microgreens
Conditions studied
- Aging — all drugs for Aging →
- Menopause — all drugs for Menopause →
- Healthy — all drugs for Healthy →
Sponsor
Colorado State University
Who can join
Adults 45 to 70, any sex, with Aging or Menopause. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Microgreens are an emerging horticultural food crop with potential to improve human health. Previous research suggests they have broad consumer acceptance and that the micronutrient and bioactive compound levels are higher than that of their mature counterparts. To date, no studies have explored the feasibility of microgreen consumption, gastrointestinal tolerance of microgreen consumption, or their potential health impacts in humans. Therefore, the overall goal of this study is to explore the feasibility and acceptability of daily microgreen consumption, gastrointestinal tolerability, and potential health impacts of red cabbage and red beet microgreens in healthy middle-aged/older men and postmenopausal women - a population inherently at risk for chronic disease, e.g. cardiovascular disease.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Sulforaphane Bioavailability in Healthy Subjects Fed a Single Serving of Fresh Broccoli Microgreens.
Bouranis JA, Wong CP, Beaver LM, Uesugi SL, et al · · 2023 · cited 6× · PMID 37893677 · DOI 10.3390/foods12203784 -
Feasibility and Tolerability of Daily Microgreen Consumption in Healthy Middle-Aged/Older Adults: A Randomized, Open-Label, Controlled Crossover Trial.
Lee SY, Michell KA, Butler MM, Smith BT, et al · · 2025 · cited 1× · PMID 39940327 · DOI 10.3390/nu17030467
Verify or expand the search:
- PubMed search for NCT04239898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging
Currently open trials in the same condition.
- NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
- NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Colorado State University trials
Trials by the same sponsor.
- NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
- NCT07297823 — Sex Differences in Cold-Induced Changes in Maximal Fat Oxidation · NA · not yet recruiting
- NCT07228013 — Examining Effects of Active Plant Engagement on College Student Well-Being and Performance · NA · active not recruiting
- NCT06834984 — Ritual Synbiotic+, a Dietary Supplement Designed to Impact Gastrointestinal Health, Mood, and Behavior in Women · NA · recruiting
- NCT06822387 — Health Without Barriers/Salud Sin Barreras- Northern Colorado · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04239898 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Colorado State University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04239898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing